Marcy Bolster to Bone Density Conservation Agents
This is a "connection" page, showing publications Marcy Bolster has written about Bone Density Conservation Agents.
Connection Strength
2.301
-
Inpatient Zoledronic Acid and Integrated Orthopedic and Fracture Liaison Services Improve Osteoporosis Treatment Rates. J Clin Endocrinol Metab. 2022 12 17; 108(1):191-197.
Score: 0.797
-
What can we do about musculoskeletal pain from bisphosphonates? Cleve Clin J Med. 2018 09; 85(9):675-678.
Score: 0.592
-
Tibial stress reaction presenting as bilateral shin pain in a man taking denosumab for giant cell tumor of the bone. Bone. 2015 Dec; 81:31-35.
Score: 0.475
-
Effects of Teriparatide on Joint Erosions in Rheumatoid Arthritis: A Randomized Controlled Trial. Arthritis Rheumatol. 2017 09; 69(9):1741-1750.
Score: 0.137
-
Current approaches to osteoporosis treatment. Curr Opin Rheumatol. 2015 May; 27(3):216-24.
Score: 0.117
-
Bisphosphonate use is associated with reduced risk of myocardial infarction in patients with rheumatoid arthritis. J Bone Miner Res. 2013 May; 28(5):984-91.
Score: 0.102
-
Consternation and questions about two vertebroplasty trials. Cleve Clin J Med. 2010 Jan; 77(1):12-6.
Score: 0.081